Hematological Findings and Alteration of Oxidative Stress Markers in Hospitalized Patients with SARS-COV-2
References
- 1. COVID-19 Clinical Management: Living Guidance. World Health Organization. [online]. Website: https://www.who.int/publications/i/item/ WHO-2019-nCoV-clinical-2021-1.
- 2. Khan M, Khan H, Khan S et al. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-center study. J Med Microbiol. 2020; 69 (8): 1114–1123.10.1099/jmm.0.001231764297732783802
- 3. Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res. 2020; 51 (5): 384–387.10.1016/j.arcmed.2020.04.019719050132402576
- 4. Ito F, Sono Y, Ito T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants. 2019; 8 (3): 72.10.3390/antiox8030072646657530934586
- 5. Zhang H, Penninger JM, Li Y et al.. Angiotensin-converting enzyme 2 (ACE2) as a SARSCoV-2 receptor: molecular mechanisms and potential therapeutic target. Int Care Med. 2020; 46(4): 586-590.10.1007/s00134-020-05985-9707987932125455
- 6. Huertas A, Montani D, Savale L et al. Endothelial cell dysfunction: A major player in SARSCoV-2 infection (COVID-19)? Eur Res J. 2020; 56 (1) 2001634.10.1183/13993003.01634-2020730183532554538
- 7. Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease. Hematol Transfus Cell Ther. 2019; 42(2): 116–117.10.1016/j.htct.2020.03.001712815432284281
- 8. Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020; 28; 10 (2): 1271.10.4081/cp.2020.1271726781032509258
- 9. Gadotti AC, Lipinski AL, Vasconcellos FT et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Rad Biol Med. 2021; 165: 184–190.10.1016/j.freeradbiomed.2021.01.044784646033524532
- 10. Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment? Pan Afr Med J 2020; 29, 35(Suppl 2): 12.10.11604/pamj.supp.2020.35.2.22877
- 11. Loffredo L, Violi F. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? Int J Cardiol. 2020; 1, 312: 136.
- 12. Zhao X, Wang K, Zuo P et al. Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients-indications for predictive, preventive, and personalized medical approach. EPMA J. 2020; 14, 11(2): 1–7.
- 13. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020; 506: 145–148.10.1016/j.cca.2020.03.022710266332178975
- 14. Long H, Nie L, Xiang X et al. D-Dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. Biomed Res Int. 2020; 2020: 6159720.10.1155/2020/6159720730118832596339
- 15. Liu Y, Gao W, Guo W et al. Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19. J Thromb Thrombolysis. 2020; 50 (4): 825–832.10.1007/s11239-020-02174-9740897832761495
- 16. Li Y, Zhao K, Wei H et al. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol. 2020; 190 (1): e24–e27.10.1111/bjh.16811727681932420615
- 17. Fu J, Kong J, Wang W et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res. 2020; 192: 3–8.10.1016/j.thromres.2020.05.006720124132407937
- 18. Peng J, Qi D, Yuan G et al. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. J Clin Lab Anal. 2020; 34(10): e23475.10.1002/jcla.23475740436832681559
- 19. Yang AP, Liu JP, Tao WQ et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020; 84: 10650410.1016/j.intimp.2020.106504715292432304994
- 20. Seyit M, Avci E, Nar R et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med. 2021; 40: 110–114.10.1016/j.ajem.2020.11.058771928133309506
- 21. NI A. Reference Values of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Mean Platelet Volume in Healthy Adults in North Central Nigeria:. J Blood Lymph. 2016; 6: 1.10.4172/2165-7831.1000143
- 22. Terpos E, Ntanasis-Stathopoulos I, Elalamy I et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95(7): 834–847.10.1002/ajh.25829726233732282949
- 23. Muhammad Y, Kani YA, Iliya S et al. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross-sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021;9: 2050312121991246.10.1177/2050312121991246787128233614035
- 24. Pincemail J, Cavalier E, Charlier C et al. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants 2021; 10: 257.10.3390/antiox10020257
- 25. Cekerevac I, Nikolic Turnic T, Draginic N et al. Predicting Severity and Intrahospital Mortality in COVID-19: The Place and Role of Oxidative Stress. Oxid Med Cell Long. 2021. 2021: 6615787.10.1155/2021/6615787
- 26. Xie J, Covassin N, Fan Z et al. “Association between hypoxemia and mortality in patients with COVID-19,” Mayo Clinic Proceedings, vol. 95, no. 6, pp. 1138–1147, 2020.
- 27. Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497–506.10.1016/S0140-6736(20)30183-5
- 28. Wang D, Hu B, Hu C et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061–1069.10.1001/jama.2020.1585704288132031570
- 29. Wu C, Chen X, Cai Y et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 80(7): 934–943.10.1001/jamainternmed.2020.0994707050932167524
- 30. Xu H, Zhong L, Deng J et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020; 12(1):8.10.1038/s41368-020-0074-x703995632094336
- 31. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol. 1999; 162(4): 2154–2161.
- 32. Liao YC, Liang WG, Chen FW et al. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002; 169(8): 4288–4297.10.4049/jimmunol.169.8.428812370360
- 33. Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul. 2020; 77:100741.10.1016/j.jbior.2020.100741733465932773102
- 34. Imran MM, Ahmad U, Usman U et al. Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity. Int J Clin Pract. 2021; 75(4): e13698.10.1111/ijcp.1369832892477
- 35. Cheng B, Hu J, Zuo X et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Microbiol Infect. 2020; 26(10): 1400–1405.10.1016/j.cmi.2020.06.033733155632622952
- 36. Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020; 12(7): 448–453.10.14740/jocmr4240
- 37. He X, Yao F, Chen J et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021; 11(1): 1830.10.1038/s41598-021-81300-w
- 38. Naymagon L, Zubizarreta N, Feld J, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res. 2020; 196: 99–105.10.1016/j.thromres.2020.08.032
- 39. Deng Y, Liu W, Liu K et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J. 2020; 133(11): 1261–1267.10.1097/CM9.0000000000000824
- 40. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 28, 395(10229): 1054 –1062.10.1016/S0140-6736(20)30566-3
- 41. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.10.1111/jth.14768716650932073213
Language: English
Page range: 5 - 13
Published on: Jul 13, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2022 Kalina Gjorgjievska, Marija Petrushevska, Dragica Zendelovska, Emilija Atanasovska, Katerina Spasovska, Milena Stevanovikj, Krsto Grozdanovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.